<DOC>
	<DOCNO>NCT00159770</DOCNO>
	<brief_summary>Evaluation antipsychotic efficacy safety ziprasidone versus olanzapine , risperidone quetiapine patient schizophrenia , schizoaffective schizophreniform disorder naturalistic condition clinical practice</brief_summary>
	<brief_title>Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Inpatients outpatient schizophrenia , schizoaffective schizophreniform disorder ( DSMIV ) . Patients without adequate current treatment ( i.e . intolerance current treatment lack efficacy current treatment ) base clinical judgement investigator A history intolerance ziprasidone , olanzapine , risperidone quetiapine ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>